Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes*
Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
Authors: R. Scott, T. Loeys, M. J. Davies, S. S. Engel, for the Sitagliptin Study 801 Group
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2158727328
